Ironwood Pharmaceuticals
IRWD
#6947
Rank
NZ$0.97 B
Marketcap
NZ$6.02
Share price
-6.70%
Change (1 day)
2.54%
Change (1 year)

Earnings for Ironwood Pharmaceuticals (IRWD)

Earnings in 2025 (TTM): NZ$0.15 Billion

According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.33 Billion. In 2024 the company made an earning of NZ$0.11 Billion, an increase over its 2023 earnings that were of -NZ$1.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ironwood Pharmaceuticals from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.15 B40.02%
2024 NZ$0.11 B-106.88%
2023 -NZ$1.65 Billion-475.59%
2022 NZ$0.43 B25.8%
2021 NZ$0.34 B84.32%
2020 NZ$0.18 B84.69%
2019 NZ$0.10 B-125.13%
2018 -NZ$0.41 Billion100.62%
2017 -NZ$0.21 Billion43.12%
2016 -NZ$0.15 Billion-42.73%
2015 -NZ$0.25 Billion-24.76%
2014 -NZ$0.33 Billion-30.49%
2013 -NZ$0.48 Billion275.65%
2012 -NZ$0.13 Billion11.56%
2011 -NZ$0.12 Billion9.38%
2010 -NZ$0.11 Billion-15.21%
2009 -NZ$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nektar Therapeutics
NKTR
-NZ$0.2 Billion-221.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.65 B 13,890.27%๐Ÿ‡ฌ๐Ÿ‡ง UK